The Beauty of Science: No Need to Think About Costs When You Live in An Ivory Tower

The recently published INSIGHT trial showed that starting HIV therapy earlier rather than later has benefit for patients 1. This should not come as a surprise considering the excellent suppressive power of current triple regimens.  The trial which enrolled 4685 Continue reading The Beauty of Science: No Need to Think About Costs When You Live in An Ivory Tower

HIV Therapy Guidance Recommendations Diverge, Show US Bias

US doctors seem to be very willing to start drugs earlier in disease, while their EU colleagues are slower and more conservative.  Recent examples: the ever-wider indication for statins, the disproportionate uptake of drugs for attention-deficit / hyperactivity and opioids Continue reading HIV Therapy Guidance Recommendations Diverge, Show US Bias